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Studies published in 2014 have helped in our understanding of the epigenetic 
mechanisms by which suboptimal nutritional exposures during in utero 
development are transmitted to subsequent generations through both the 
maternal and paternal line. Advances include identification of common loci that 
are vulnerable to in utero under-nutrition and over-nutrition as well as those 
that occur tissue-wide. 
 
An association between birth weight and development of traditionally adult-
onset diseases such as type 2 diabetes mellitus (T2DM) and cardiovascular disease in 
later life was first demonstrated more than two decades ago.1 These observations led 
to the concept of the developmental origins of health and disease—the idea that the 
environment to which we are exposed during critical periods of development has a 
permanent effect on our tissue structure and metabolism and consequently on our 
long-term health.2 Environmental factors now known to have such effects include 
maternal nutrition, maternal smoking, maternal stress and toxins. Despite the wealth 
of evidence for these ‘programmed’ effects, the precise mechanisms by which an 
event in early life can have a permanent effect on tissue function many years later, 
following multiple rounds of cell division, remain poorly understood. Nevertheless, 
epigenetic processes have emerged as a conceptually attractive mechanism in this 
context. The term ‘epigenetics’ was first used by Conrad Waddington to define the 
“interactions of genes with their environment which bring the phenotype into being”.3 
The epigenetic processes that mediate this interaction are now recognised to include 
DNA methylation, covalent modifications of histone tails (including acetylation and 
methylation) and the effects of noncoding RNAs (such as microRNAs and long 
noncoding RNAs)4. Over the last year substantial progress has been made in 
determining the loci within the genome through which epigenetic programming of 
health and disease operates.  
 
 Initial studies in the field of epigenetic programming of health and disease 
focused on the detrimental effects of suboptimal experiences in utero that are 
mediated through changes in maternal metabolism and/or behaviour. However, in the 
past few years, paternal factors have been shown to also have transgenerational 
effects on the offspring. In a study in rats, for example, paternal high-fat feeding at 
the time of conception was demonstrated to influence glucose tolerance and 
pancreatic β-cell function of female offspring.5 A landmark study published in 2014 
by Radford and colleagues provided evidence that exposure to suboptimal nutrition 
during fetal life leads to changes in the germ-cell DNA methylome of male offspring 
even when these male offspring are nourished normally from weaning.6. The 
researchers demonstrated these effects using an established mouse model of maternal 
under-nutrition that leads to low birth weight and glucose intolerance in male and 
female F1 offspring. These phenotypic differences are transmitted through the 
paternal line to the F2 offspring. Using methylated DNA immunoprecipitation–
sequencing technology to analyse genome-wide methylation patterns, the 
investigators identified 111 regions in the F1 sperm from the maternally 
undernourished male offspring that were hypomethylated compared with the 
equivalent regions of sperm from control offspring. Despite these differences not 
being retained in late-gestation somatic tissues from F2 offspring bred from the F1 
male offspring, the alterations in the adult male F1 germline might provide a 
mechanism by which transgenerational programming occurs through the paternal line.  
 
 Although evidence for the effects of maternal diet on the epigenome of the 
offspring in animal models is growing, there is a paucity of data showing such effects 
in humans. One of the few studies in humans to demonstrate such changes came from 
the analysis of individuals who were in utero during the Dutch Hunger Winter and 
whom, therefore, were exposed to extreme under-nutrition during fetal life.7 In 2014, 
Dominguez-Salas and colleagues showed that more natural variation in maternal diet 
during early pregnancy can cause persistent changes in DNA methylation in the 
offspring.8. To demonstrate this link they analysed samples collected from children 
born to mothers either during the rainy (hungry) season or the dry (harvest) season. 
As demonstrated previously, pregnancies during these two seasons vary greatly in 
nutrient intake including that of key methyl donor substrates such as methionine and 
folate. Candidate methylation analysis of white blood cells and hair follicle samples 
(selected as mesodermal and ectodermal tissues, respectively) from the offspring of 
these mothers demonstrated increased methylation of six metastable alleles in 
children who were born in the rainy season. Metastable epialleles are regions of the 
genome at which DNA methylation is established stochastically in the early embryo 
and then maintained in differentiated tissues. This approach to focus on metastable 
epialleles therefore negates one of the limitations of many human epigenetic studies 
in the field of metabolic programming. These studies have primarily been carried out 
in clinically accessible tissues, such as white blood cells, and the question has often 
been raised as to whether any changes identified are relevant to functionally important 
metabolic tissues and, therefore, whether they provide insight into the biological 
mechanisms by which epigenetic programming occurs.  
 
 Even when differences are identified in metastable epialleles in clinically 
accessible tissues, which reflect methylation in a tissue involved in metabolism, an 
important next step is to establish that these changes are functionally relevant both in 
terms of regulating transcription and triggering a disease process, such as 
development of T2DM. One approach to start to address this issue is to define the 
methylome of metabolically relevant tissues from an individual with the disease and 
compare it with that of healthy individuals. In 2014, this approach has been adopted 
by Dayeh and colleagues, who took a genome-wide strategy to compare DNA 
methylation patterns in pancreatic islets from individuals with T2DM and those from 
glucose-tolerant individuals.9 The researchers identified 853 genes that showed 
differential methylation in islets from patients with T2DM compared with islets from 
control individuals. These genes included some that were previously implicated in the 
pathogenesis of T2DM (including FTO and TCF7L2), as well as some not previously 
associated with T2DM risk. Importantly, the investigators demonstrated that in at 
least some of the loci the methylation change was accompanied by a reciprocal 
change in the corresponding mRNA and that in vitro modulation of the transcript was 
associated with differences in  pancreatic β-cell function. 
 
 A key question in the field of developmental programming has been finding 
an explanation for how a range of suboptimal exposures to diverse environmental 
factors in early life can lead to a common metabolic phenotypic outcomes such as 
T2DM in later life. Is there one common response pathway initiated when a fetus 
senses that it is in an inappropriate environment? What could the programming factor 
being sensed be, and which loci within the genome are most vulnerable to these 
effects? Some of these questions have been addressed in 2014 by Quilter and 
colleagues, who took a genome-wide approach to compare cord-blood DNA 
methylation between babies who were either born to mothers who developed 
gestational diabetes mellitus, had experienced growth restraint in utero, or did not 
belong to one of these two groups (i.e., whose mothers did not develop gestational 
diabetes mellitus and who did not display any indication of in utero growth restraint.10 
Although sample size was small, the research team identified eight genes that were 
differentially methylated in the two groups exposed to a suboptimal environment in 
utero compared with the controls. These findings provide proof of principle that 
epigenetic programming of common genes might explain why exposure to a range of 
different suboptimal environments in utero can lead to a common metabolic 
phenotypic outcome, such as T2DM. 
 
 Studies in animal models and human cohorts support the now widely accepted 
idea that exposure to a suboptimal environment during critical periods of development 
can have a long-term effect on the metabolic health of an individual. Furthermore, 
these detrimental metabolic consequences can be transmitted to the next generation 
through both the maternal and the paternal line. These effects are associated with 
changes in epigenetic marks, such as DNA methylation, in the offspring. The next 
challenge to take the field forward will be to demonstrate a causal relationship 
between loci-specific programmed epigenetic alterations in response to an adverse 
early environment and metabolic disease phenotypes later in life. 
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Key advances 
• Maternal nutrition during pregnancy alters the germline DNA methylome of 
male offspring in adulthood6  
• Maternal diet in humans at the time of conception modulates DNA 
methylation in the offspring at metastable epialleles8  
• Human islets from individuals with type 2 diabetes mellitus have a different 
methylome compared with those from glucose-tolerant individuals9  
• Exposure to different suboptimal environments in utero can lead to common 
methylation changes in the offspring10  
